In summary, our meta-analysis indicates that APC promoter hypermethylation is an early event of carcinogenesis of CRC, and APC methylation combined with the mutation of other genes could be a valuable biomarker for diagnosis and prognosis of CRC. The gene discussed is APC; the disease is colorectal carcinoma.